Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

PS48

based on 1 citations in multiple journalsPS4814.1 4
An allosteric PDK1 activator
Catalog #: 1869
SKU-Size Size Price Qty
1869-5 5 mg
$80.00
1869-25 25 mg
$285.00
1869-100 100 mg
$835.00
More Sizes Get Quote

Product Details

Alternate Name (2Z)-5-(4-Chlorophenyl)-3-phenyl-2-pentenoic acid
Appearance White to off-white solid
CAS # 1180676-32-7
Molecular Formula C₁₇H₁₅ClO₂
Molecular Weight 286.75
Purity ≥95% by HPLC
Solubility DMSO (100 mM) or EtOH (50 mM)
SMILES C1=CC=C(C=C1)C(=CC(=O)O)CCC2=CC=C(C=C2)Cl
InChi InChI=1S/C17H15ClO2/c18-16-10-7-13(8-11-16)6-9-15(12-17(19)20)14-4-2-1-3-5-14/h1-5,7-8,10-12H,6,9H2,(H,19,20)/b15-12-
InChi Key LLJYFDRQFPQGNY-QINSGFPZSA-N
PubChem CID 44141940
MDL Number MFCD17215962
Handling Protect from air and light
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

An allosteric phosphoinositide-dependent protein kinase-1 (PDK1) activator (Kd = 10.3 μM). Binds exclusively to the PIF-binding pocket of PDK1, distinct from the ATP binding site. It has recently been found that a combination of PS48, sodium butyrate (Cat. No. 1609-1000), a histone deacetylase inhibitor and the gene Oct-4, could enhance the reprogramming efficiency of keratinocytes isolated from human skin or hair follicles over 25-fold.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Aflaki et al., Macrophage Models of Gaucher Disease for Evaluating Disease Pathogenesis and Candidate Drugs. Science Translational Medicine, Jun 2014; 6: 240ra73.
For more citations of this product click here